Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022
Home » Veterinary Diagnostics » Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
Connexity® The Annual Conference of the American Animal Hospital AssociationNashville
September 14, 2022 - September 17, 2022
LexaGene will be exhibiting AAHA's Connexity Event in September.
In this webinar, Dr. Jane Sykes details data from a multi-center study using the MiQLab® System for diagnosing urinary tract infections.